GSK2241658A
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 25, 2014
Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma
(clinicaltrials.gov)
- P1; N=34; Active, not recruiting; Sponsor: GlaxoSmithKline; Trial primary completion date: Aug 2014 ->Jul 2015
Trial primary completion date • Biosimilar • Melanoma • Oncology
1 to 1
Of
1
Go to page
1